サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1421658

尿路結石症管理デバイス市場、シェア、規模、動向、産業分析レポート：治療タイプ別、最終用途別、地域別、セグメント別予測、2023年～2032年

Urolithiasis Management Devices Market Share, Size, Trends, Industry Analysis Report, By Treatment Type (Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy); By End-use; By Region, And Segment Forecasts, 2023 - 2032
出版日: | 発行: Polaris Market Research | ページ情報: 英文 118 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
尿路結石症管理デバイス市場、シェア、規模、動向、産業分析レポート：治療タイプ別、最終用途別、地域別、セグメント別予測、2023年～2032年
出版日: 2023年11月23日
発行: Polaris Market Research
ページ情報: 英文 118 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、世界の尿路結石症管理デバイス市場規模は2032年までに35億1,000万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

尿路結石の罹患率の上昇は、治療オプションの進歩を促しています。欧州泌尿器科学会によると、尿路結石症は有病率10％の生活習慣病であり、体系的な治療アプローチが必要です。尿路結石症は、腎臓、尿管、膀胱を含む泌尿器系に結石が形成されることを指します。米国、カナダ、ドイツでは重大なヘルスケア問題となっており、ほとんどの症例で50％近い再発率を示しています。

尿路結石症は、生活習慣の改善、食事管理、基本的な薬物療法で対処できますが、激しい痛みを引き起こす大きな結石の除去には、さまざまな治療アプローチが必要です。結石の大きさ、位置、解剖学的変異に応じて、侵襲的結石術と非侵襲的結石術の両方があります。

最近の研究では、腎結石の有病率は男女を問わず約10人に1人にまで上昇しています。さらに、これらの患者の半数は、生涯を通じて複数の症状を伴う腎結石を経験する可能性が高いです。マクロファージと呼ばれる炎症細胞は、前駆物質から腎結石の発生に影響を及ぼします。最近の研究では、臨床的に重要な結石を発症した患者では、腎臓内のカルシウム沈着量の増加が炎症性マクロファージの活性化を引き起こし、対照群とは対照的であることが示されました。

体腔内結石破砕療法では、内視鏡を用いて結石を同定し、より小さな破片に分解します。超音波やレーザーなどの技術を使用して結石を崩壊させ、より小さな破片が尿路系を通過できるようにします。結石のない状態を実現する高い有効性から、体腔内結石破砕術は予測期間中に好ましい治療選択肢になると予想されます。さらに、経皮的腎結石除去術は、体外または体内結石破砕術が無効な場合に、より大きな結石を除去するために使用される手術法であり、通常1週間の入院が必要です。

内視鏡やガイドワイヤー、メス、バスケットなどのマイクロアクセサリーのような高度な手術技術のイントロダクションは、短期間で効率的に尿路系から結石を除去するための低侵襲手術の受け入れを大幅に改善しました。

尿路結石症管理デバイス市場レポートハイライト

  • 2022年には、体腔内結石破砕術が、その高い効率性、男性の腎結石に最も適していることから、最大の市場シェアを占めました。
  • 体腔内結石破砕術セグメントは、病院コストの上昇と入院期間の短縮を理由に、最大の市場シェアを占めました。
  • 2022年には、北米地域が最大の市場シェアを占め、腎結石症例の増加、外科的介入、消費者の認識などが背景にあります。
  • 主な市場プレイヤーは、Cook Medical、ConMed、DirexGroup、Dornier MedTech、KARL STORZ、Olympus、Richard Wolf、Siemensヘルスケアなどです。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の尿路結石症管理デバイス市場に関する洞察

  • 尿路結石症管理デバイス市場- 業界スナップショット
  • 尿路結石症管理デバイスの市場力学
    • 促進要因と機会
      • 肥満の発生率の増加
      • 高齢化人口の増加
    • 抑制要因と課題
      • 高額な治療費
  • PESTLE分析
  • 尿路結石管理装置の業界動向
  • バリューチェーン分析
  • COVID-19感染症の影響分析

第5章 世界の尿路結石症管理デバイス市場、治療タイプ別

  • 主な調査結果
  • イントロダクション
  • 体外衝撃波結石破砕術（ESWL）
  • 体内砕石術
  • 経皮的腎結石切開術
  • その他

第6章 世界の尿路結石症管理デバイス市場、最終用途別

  • 主な調査結果
  • イントロダクション
  • 病院とクリニック
  • 外来手術センター（ASC）

第7章 世界の尿路結石症管理デバイス市場、地域別

  • 主な調査結果
  • イントロダクション
    • 尿路結石症管理デバイス市場評価、地域、2019-2032年
  • 尿路結石症管理デバイス市場-北米
    • 北米：尿路結石症管理デバイス市場、最終用途別、2019～2032年
    • 北米：尿路結石症管理デバイス市場、治療タイプ別、2019～2032年
    • 尿路結石症管理デバイス市場-米国
    • 尿路結石症管理デバイス市場- カナダ
  • 尿路結石症管理デバイス市場- 欧州
    • 欧州：尿路結石症管理デバイス市場、最終用途別、2019～2032年
    • 欧州：尿路結石症管理デバイス市場、治療タイプ別、2019～2032年
    • 尿路結石症管理デバイス市場- 英国
    • 尿路結石症管理デバイス市場- フランス
    • 尿路結石症管理デバイス市場- ドイツ
    • 尿路結石症管理デバイス市場- イタリア
    • 尿路結石症管理デバイス市場- スペイン
    • 尿路結石症管理デバイス市場- オランダ
    • 尿路結石症管理デバイス市場- ロシア
  • 尿路結石症管理デバイス市場- アジア太平洋
    • アジア太平洋：尿路結石症管理デバイス市場、最終用途別、2019～2032年
    • アジア太平洋：尿路結石症管理デバイス市場、治療タイプ別、2019～2032年
    • 尿路結石症管理デバイス市場- 中国
    • 尿路結石症管理デバイス市場- インド
    • 尿路結石症管理デバイス市場- マレーシア
    • 尿路結石症管理デバイス市場- 日本
    • 尿路結石症管理デバイス市場- インドネシア
    • 尿路結石症管理デバイス市場- 韓国
  • 尿路結石症管理デバイス市場-中東およびアフリカ
    • 中東およびアフリカ：尿路結石症管理デバイス市場、最終用途別、2019～2032年
    • 中東およびアフリカ：尿路結石症管理デバイス市場、治療タイプ別、2019～2032年
    • 尿路結石症管理デバイス市場- サウジアラビア
    • 尿路結石症管理デバイス市場- アラブ首長国連邦
    • 尿路結石症管理デバイス市場- イスラエル
    • 尿路結石症管理デバイス市場- 南アフリカ
  • 尿路結石症管理デバイス市場-ラテンアメリカ
    • ラテンアメリカ：尿路結石症管理デバイス市場、最終用途別、2019-2032年
    • ラテンアメリカ：尿路結石症管理デバイス市場、治療タイプ別、2019～2032年
    • 尿路結石症管理デバイス市場- メキシコ
    • 尿路結石症管理デバイス市場- ブラジル
    • 尿路結石症管理デバイス市場- アルゼンチン

第8章 競合情勢

  • 拡張と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第9章 企業プロファイル

  • Allengens
  • Boston Scientific
  • BD
  • Cook Medical
  • ConMed
  • DirexGroup
  • Dornier MedTech
  • KARL STORZ
  • Potent Optotronic
  • HealthTronics
  • Lumenis
  • Olympus
  • Richard Wolf
  • Siemens Healthcare
図表

List of Tables

  • Table 1 Global Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 2 Global Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 3 Urolithiasis Management Devices Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 4 North America: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 5 North America: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 6 U.S.: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 7 U.S.: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 8 Canada: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 9 Canada: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 10 Europe: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 11 Europe: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 12 UK: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 13 UK: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 14 France: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 15 France: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 16 Germany: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 17 Germany: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 18 Italy: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 19 Italy: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 20 Spain: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 21 Spain: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 22 Netherlands: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 23 Netherlands: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 24 Russia: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 25 Russia: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 26 Asia Pacific: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 27 Asia Pacific: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 28 China: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 29 China: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 30 India: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 31 India: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 32 Malaysia: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 33 Malaysia: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 34 Japan: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 35 Japan: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 36 Indonesia: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 37 Indonesia: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 38 South Korea: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 39 South Korea: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 40 Middle East & Africa: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 41 Middle East & Africa: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 42 Saudi Arabia: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 43 Saudi Arabia: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 44 UAE: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 45 UAE: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 46 Israel: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 47 Israel: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 48 South Africa: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 49 South Africa: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 50 Latin America: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 51 Latin America: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 52 Mexico: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 53 Mexico: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 54 Brazil: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 55 Brazil: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 56 Argentina: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 57 Argentina: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)

List of Figures

  • Figure 1 Global Urolithiasis Management Devices Market, 2019-2032 (USD Billion)
  • Figure 2 Integrated Ecosystem
  • Figure 3 Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4 Market by Geography
  • Figure 5 Porter's Five Forces
  • Figure 6 Market by End Use
  • Figure 7 Global Urolithiasis Management Devices Market, by End Use, 2022 & 2032 (USD Billion)
  • Figure 8 Market by Treatment Type
  • Figure 9 Global Urolithiasis Management Devices Market, by Treatment Type, 2022 & 2032 (USD Billion)
  • Figure 10 Urolithiasis Management Devices Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 11 Strategic Analysis - Urolithiasis Management Devices Market
目次
Product Code: PM3989

The global urolithiasis management devices market size is expected to reach USD 3.51 billion by 2032, according to a new study by Polaris Market Research. The report "Urolithiasis Management Devices Market Share, Size, Trends, Industry Analysis Report, By Treatment Type (Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy), By End-use, By Region, And Segment Forecasts, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rising incidence of urinary stones has driven advancements in treatment options. According to the European Association of Urology, it is a prevalent lifestyle disorder with a 10% prevalence rate, necessitating a systematic treatment approach. Urolithiasis refers to the formation of stones in the urinary system, including the kidneys, ureters, & bladder. It poses a significant healthcare concern in the U.S., Canada, & Germany, with a recurrence rate of nearly 50 percent in most of the cases.

While lifestyle changes, controlled diet, and basic medication can manage urolithiasis, various treatment approaches are required for the removal of large stones causing severe pain. Depending on the stone size, location, & anatomical variations, both invasive & non-invasive stone procedures are available.

Kidney stone disease is a prevalent urologic condition among adults in the U.S. Recent studies indicate that the prevalence of kidney stones has risen to approximately 1 in 10 individuals of all genders. Additionally, half of these individuals are likely to experience multiple symptomatic kidney stones throughout their lives. Inflammatory cells called macrophages influence the development of kidney stones from precursor materials. A recent study indicated that elevated calcium deposits in the kidney led to the activation of proinflammatory macrophages in patients who developed clinically significant stones, contrasting with the control group.

Intracorporeal lithotripsy treatments involve identifying and breaking down stones into smaller fragments using endoscopy. Techniques like ultrasound or laser are employed to disintegrate stones, allowing the passage of smaller pieces through the urinary system. Due to its high effectiveness in achieving a stone-free state, intracorporeal lithotripsy is expected to be a preferred treatment option in the forecast period. Additionally, percutaneous nephrolithotomy is a surgical method used for removing larger stones when extracorporeal or intracorporeal lithotripsies are ineffective, typically requiring a week-long hospital stay.

The introduction of advanced surgical technologies like endoscopy and micro accessories such as guidewires, scalpels, and baskets has significantly improved the acceptance of minimally invasive surgeries for efficiently removing stones from the urinary system within a short timeframe.

Urolithiasis Management Devices Market Report Highlights

  • In 2022, the intra-corporeal lithotripsy segment held the largest market share, as its high efficiency rate, and most suitable for renal stones in men
  • The intra-corporeal lithotripsy segment held the largest market share, on account for rising hospitals costs, and shortened hospital stays.
  • In 2022, North America region dominated the largest market share, rising cases of renal stones, surgical interventions, and awareness among consumer
  • The key market players include Cook Medical, ConMed, DirexGroup, Dornier MedTech, KARL STORZ, Olympus, Richard Wolf, and Siemens Healthcare.

Polaris Market Research has segmented the Urolithiasis management devices market report based on treatment type, end use, and region:

Urolithiasis Management Devices, Treatment Type Outlook (Revenue - USD Billion, 2023 - 2032)

  • Extracorporeal Shock Wave Lithotripsy (ESWL)
  • Intracorporeal Lithotripsy
  • Percutaneous Nephrolithotomy
  • Others

Urolithiasis Management Devices, End Use Outlook (Revenue - USD Billion, 2023 - 2032)

  • Hospitals & Clinics
  • Ambulatory Surgical Centers (ASCs)

Urolithiasis Management Devices, Regional Outlook (Revenue - USD Billion, 2023 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Urolithiasis Management Devices Market Insights

  • 4.1. Urolithiasis Management Devices Market - Industry Snapshot
  • 4.2. Urolithiasis Management Devices Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing incidence of obesity
      • 4.2.1.2. Increasing Aging Population
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Treatment Costs
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Urolithiasis Management Devices Industry trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Urolithiasis Management Devices Market, by Treatment Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Urolithiasis Management Devices, by Treatment Type, 2019-2032 (USD Billion)
  • 5.3. Extracorporeal Shock Wave Lithotripsy (ESWL)
    • 5.3.1. Global Urolithiasis Management Devices Market, by Extracorporeal Shock Wave Lithotripsy (ESWL), by Region, 2019-2032 (USD Billion)
  • 5.4. Intracorporeal Lithotripsy
    • 5.4.1. Global Urolithiasis Management Devices Market, by Intracorporeal Lithotripsy, by Region, 2019-2032 (USD Billion)
  • 5.5. Percutaneous Nephrolithotomy
    • 5.5.1. Global Urolithiasis Management Devices Market, by Percutaneous Nephrolithotomy, by Region, 2019-2032 (USD Billion)
  • 5.6. Others
    • 5.6.1. Global Urolithiasis Management Devices Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Urolithiasis Management Devices Market, by End Use

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • 6.3. Hospitals & Clinics
    • 6.3.1. Global Urolithiasis Management Devices Market, by Hospitals & Clinics, by Region, 2019-2032 (USD Billion)
  • 6.4. Ambulatory Surgical Centers (ASCs)
    • 6.4.1. Global Urolithiasis Management Devices Market, by Ambulatory Surgical Centers (ASCs), by Region, 2019-2032 (USD Billion)

7. Global Urolithiasis Management Devices Market, by Geography

  • 7.1. Key findings
  • 7.2. Introduction
    • 7.2.1. Urolithiasis Management Devices Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 7.3. Urolithiasis Management Devices Market - North America
    • 7.3.1. North America: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
    • 7.3.2. North America: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.3.3. Urolithiasis Management Devices Market - U.S.
      • 7.3.3.1. U.S.: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.3.3.2. U.S.: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.3.4. Urolithiasis Management Devices Market - Canada
      • 7.3.4.1. Canada: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.3.4.2. Canada: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • 7.4. Urolithiasis Management Devices Market - Europe
    • 7.4.1. Europe: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
    • 7.4.2. Europe: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.4.3. Urolithiasis Management Devices Market - UK
      • 7.4.3.1. UK: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.4.3.2. UK: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.4.4. Urolithiasis Management Devices Market - France
      • 7.4.4.1. France: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.4.4.2. France: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.4.5. Urolithiasis Management Devices Market - Germany
      • 7.4.5.1. Germany: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.4.5.2. Germany: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.4.6. Urolithiasis Management Devices Market - Italy
      • 7.4.6.1. Italy: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.4.6.2. Italy: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.4.7. Urolithiasis Management Devices Market - Spain
      • 7.4.7.1. Spain: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.4.7.2. Spain: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.4.8. Urolithiasis Management Devices Market - Netherlands
      • 7.4.8.1. Netherlands: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.4.8.2. Netherlands: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.4.9. Urolithiasis Management Devices Market - Russia
      • 7.4.9.1. Russia: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.4.9.2. Russia: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • 7.5. Urolithiasis Management Devices Market - Asia Pacific
    • 7.5.1. Asia Pacific: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
    • 7.5.2. Asia Pacific: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.5.3. Urolithiasis Management Devices Market - China
      • 7.5.3.1. China: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.5.3.2. China: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.5.4. Urolithiasis Management Devices Market - India
      • 7.5.4.1. India: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.5.4.2. India: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.5.5. Urolithiasis Management Devices Market - Malaysia
      • 7.5.5.1. Malaysia: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.5.5.2. Malaysia: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.5.6. Urolithiasis Management Devices Market - Japan
      • 7.5.6.1. Japan: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.5.6.2. Japan: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.5.7. Urolithiasis Management Devices Market - Indonesia
      • 7.5.7.1. Indonesia: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.5.7.2. Indonesia: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.5.8. Urolithiasis Management Devices Market - South Korea
      • 7.5.8.1. South Korea: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.5.8.2. South Korea: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • 7.6. Urolithiasis Management Devices Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
    • 7.6.2. Middle East & Africa: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.6.3. Urolithiasis Management Devices Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.6.3.2. Saudi Arabia: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.6.4. Urolithiasis Management Devices Market - UAE
      • 7.6.4.1. UAE: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.6.4.2. UAE: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.6.5. Urolithiasis Management Devices Market - Israel
      • 7.6.5.1. Israel: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.6.5.2. Israel: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.6.6. Urolithiasis Management Devices Market - South Africa
      • 7.6.6.1. South Africa: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.6.6.2. South Africa: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • 7.7. Urolithiasis Management Devices Market - Latin America
    • 7.7.1. Latin America: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
    • 7.7.2. Latin America: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.7.3. Urolithiasis Management Devices Market - Mexico
      • 7.7.3.1. Mexico: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.7.3.2. Mexico: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.7.4. Urolithiasis Management Devices Market - Brazil
      • 7.7.4.1. Brazil: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.7.4.2. Brazil: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.7.5. Urolithiasis Management Devices Market - Argentina
      • 7.7.5.1. Argentina: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.7.5.2. Argentina: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Allengens
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Boston Scientific
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. BD
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Cook Medical
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. ConMed
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. DirexGroup
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. Dornier MedTech
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. KARL STORZ
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Potent Optotronic
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. HealthTronics
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development
  • 9.11. Lumenis
    • 9.11.1. Company Overview
    • 9.11.2. Financial Performance
    • 9.11.3. Product Benchmarking
    • 9.11.4. Recent Development
  • 9.12. Olympus
    • 9.12.1. Company Overview
    • 9.12.2. Financial Performance
    • 9.12.3. Product Benchmarking
    • 9.12.4. Recent Development
  • 9.13. Richard Wolf
    • 9.13.1. Company Overview
    • 9.13.2. Financial Performance
    • 9.13.3. Product Benchmarking
    • 9.13.4. Recent Development
  • 9.14. Siemens Healthcare
    • 9.14.1. Company Overview
    • 9.14.2. Financial Performance
    • 9.14.3. Product Benchmarking
    • 9.14.4. Recent Development